Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta-analysis.

Da ZhouDonglai ChenPeidong SongZihao HuSukai XuRongying ZhuYongbing Chen

Published in: Journal of evidence-based medicine (2024)

Neoadjuvant therapy do not significantly increase the incidence of AL after esophagectomy. Administration of irradiation with a moderate dose is not associated with elevated risk in AL. Clinicians can be less apprehensive about prescribing nCRT.

Keyphrases

rectal cancer
locally advanced
lymph node
primary care
risk factors
palliative care
stem cells
high intensity
cell therapy
adverse drug
mesenchymal stem cells
radiation induced